Wang X, Jia Y, Li Q, Yang Q, Liu Y, Wei B
Oncol Res. 2024; 32(5):933-941.
PMID: 38686051
PMC: 11055999.
DOI: 10.32604/or.2023.042581.
Chiloiro S, De Marinis L
Rev Endocr Metab Disord. 2023; 24(2):283-295.
PMID: 36658300
PMC: 10023617.
DOI: 10.1007/s11154-022-09782-1.
Sharifulina S, Khaitin A, Guzenko V, Kalyuzhnaya Y, Dzreyan V, Logvinov A
Biomedicines. 2022; 10(10).
PMID: 36289917
PMC: 9599860.
DOI: 10.3390/biomedicines10102655.
Krzysiek-Maczka G, Targosz A, Wrobel T, Paw M, Szczyrk U, Opila J
Am J Cancer Res. 2022; 12(3):1337-1371.
PMID: 35411238
PMC: 8984895.
Crespo D, Skaftnesmo K, Kjaerner-Semb E, Yilmaz O, Norberg B, Olausson S
Front Endocrinol (Lausanne). 2022; 13:826920.
PMID: 35370944
PMC: 8964956.
DOI: 10.3389/fendo.2022.826920.
SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth Targeting VEGFA.
Wang X, Fang Y, Zhou Y, Guo X, Xu K, Li C
Front Endocrinol (Lausanne). 2020; 11:566761.
PMID: 33362712
PMC: 7756115.
DOI: 10.3389/fendo.2020.566761.
Late spontaneous bilateral intraocular lens subluxation accompanied with intraocular pressure elevation in a patient with acromegaly.
Chang Y, Chen S
Taiwan J Ophthalmol. 2020; 10(2):147-150.
PMID: 32874848
PMC: 7442100.
DOI: 10.4103/tjo.tjo_76_19.
The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.
Ilie M, Vasiljevic A, Raverot G, Bertolino P
Cancers (Basel). 2019; 11(10).
PMID: 31640258
PMC: 6826349.
DOI: 10.3390/cancers11101605.
Molecular Network Basis of Invasive Pituitary Adenoma: A Review.
Yang Q, Li X
Front Endocrinol (Lausanne). 2019; 10:7.
PMID: 30733705
PMC: 6353782.
DOI: 10.3389/fendo.2019.00007.
Processed eggshell membrane powder regulates cellular functions and increase MMP-activity important in early wound healing processes.
Vuong T, Ronning S, Ahmed T, Brathagen K, Host V, Hincke M
PLoS One. 2018; 13(8):e0201975.
PMID: 30080894
PMC: 6078314.
DOI: 10.1371/journal.pone.0201975.
Landscape of Molecular Events in Pituitary Apoplexy.
Gupta P, Dutta P
Front Endocrinol (Lausanne). 2018; 9:107.
PMID: 29615979
PMC: 5869273.
DOI: 10.3389/fendo.2018.00107.
Tissue inhibitors of metalloproteinase-expressing cells in human anterior pituitary and pituitary adenoma.
Tofrizal A, Fujiwara K, Azuma M, Kikuchi M, Jindatip D, Yashiro T
Med Mol Morphol. 2017; 50(3):145-154.
PMID: 28353090
DOI: 10.1007/s00795-017-0155-x.
Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients.
Cagri Karci A, Canturk Z, Tarkun I, Cetinarslan B
Endocrine. 2017; 57(1):148-155.
PMID: 28332074
DOI: 10.1007/s12020-017-1283-8.
Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?.
Glebauskiene B, Liutkeviciene R, Vilkeviciute A, Kriauciuniene L, Jakstiene S, Zlatkute E
Dis Markers. 2017; 2017:5839528.
PMID: 28194042
PMC: 5282418.
DOI: 10.1155/2017/5839528.
Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.
Isaacson K, Jensen M, Subrahmanyam N, Ghandehari H
J Control Release. 2017; 259:62-75.
PMID: 28153760
PMC: 5537048.
DOI: 10.1016/j.jconrel.2017.01.034.
Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide.
Huang C, Yi X, Kong D, Chen L, Min G
Oncotarget. 2016; 7(32):52230-52238.
PMID: 27447567
PMC: 5239547.
DOI: 10.18632/oncotarget.10735.
Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.
Liu H, Gu W, Wang C, Ji X, Mu Y
Medicine (Baltimore). 2016; 95(24):e3904.
PMID: 27310993
PMC: 4998479.
DOI: 10.1097/MD.0000000000003904.
Role of MMP-2 (-1306 C/T) Polymorphism in Pituitary Adenoma.
Glebauskiene B, Liutkeviciene R, Vilkeviciute A, Kriauciuniene L, Bernotas G, Tamasauskas A
Scientifica (Cairo). 2016; 2016:2839697.
PMID: 27051552
PMC: 4804086.
DOI: 10.1155/2016/2839697.
Analysis of Circulating Endostatin and Vascular Endothelial Growth Factor in Patients with Pituitary Adenoma Treated by Stereotactic Radiosurgery: A Preliminary Study.
Lee K, Park S, Park K, Hwang J, Hwang S
Brain Tumor Res Treat. 2015; 3(2):89-94.
PMID: 26605263
PMC: 4656901.
DOI: 10.14791/btrt.2015.3.2.89.
Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.
Hua Y, Nair S
Biochim Biophys Acta. 2014; 1852(2):195-208.
PMID: 24815358
PMC: 4225191.
DOI: 10.1016/j.bbadis.2014.04.032.